Review of the Use of SWAP and FDT for the Early Detection of Visual Field Loss

References (82)

1. 1 The number of people with glaucoma worldwide in 2010 and 2020 [DOI]
2. 2 Number of people with glaucoma worldwide. [DOI]
3. 3 Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons.
4. 4 Clinical Decisions In Glaucoma
5. 5 The 'blue-on' opponent pathway in primate retina originates from a distinct bistratified ganglion cell type [DOI]
6. 6 Chronic Human Glaucoma Causing Selectively Greater Loss of Large Optic Nerve Fibers [DOI]
7. 7 Risk Factors for Glaucoma Onset and Progression [DOI]
8. 8 Ganglion cell losses underlying visual field defects from experimental glaucoma.
9. 9 Foveal ganglion cell loss is size dependent in experimental glaucoma.
10. 10 Frequency Doubling in Visual Responses*† [DOI]
11. 11 A comparison of koniocellular, magnocellular and parvocellular receptive field properties in the lateral geniculate nucleus of the owl monkey (Aotus trivirgatus) [DOI]
12. 12 Threshold and Variability Properties of Matrix Frequency-Doubling Technology and Standard Automated Perimetry in Glaucoma [DOI]
13. 13 Progression of Early Glaucomatous Visual Field Loss as Detected by Blue-on-Yellow and Standard White-on-White Automated Perimetry [DOI]
14. 14 Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss [DOI]
15. 15 Frequency-doubling technology perimetry [DOI]
16. 16 Automated perimetry [DOI]
17. 17 A Statistical Approach to the Evaluation of Covariate Effects on the Receiver Operating Characteristic Curves of Diagnostic Tests in Glaucoma [DOI]
18. 18 The Economic Burden of Glaucoma and Ocular Hypertension [DOI]
19. 19 Detection of Early Visual Field Loss in Glaucoma Using Frequency-Doubling Perimetry and Short-Wavelength Automated Perimetry [DOI]
20. 20 Can Frequency-doubling Technology and Short-wavelength Automated Perimetries Detect Visual Field Defects Before Standard Automated Perimetry in Patients With Preperimetric Glaucoma? [DOI]
21. 21 Diagnostic Accuracy of the Matrix 24-2 and Original N-30 Frequency-Doubling Technology Tests Compared with Standard Automated Perimetry [DOI]
22. 22 Short-wavelength Color Visual Fields in Glaucoma Suspects at Risk [DOI]
23. 23 Accuracy of glaucoma detection with frequency-doubling perimetry [DOI]
24. 24 Characteristics of the Normative Database for the Humphrey Matrix Perimeter [DOI]
25. 25 Normal Aging Effects for Frequency Doubling Technology Perimetry [DOI]
26. 26 Frequency Doubling Technology Perimetry With the Humphrey Matrix 30-2 Test [DOI]
27. 27 Early Glaucoma Detection Using the Humphrey Matrix Perimeter, GDx VCC, Stratus OCT, and Retinal Nerve Fiber Layer Photography [DOI]
28. 28 Clinical evaluation of frequency doubling technology perimetry using the Humphrey Matrix 24-2 threshold strategy [DOI]
29. 29 Recent developments in perimetry: test stimuli and procedures [DOI]
30. 30 Diagnostic Sensitivity of Fast Blue–Yellow and Standard Automated Perimetry in Early Glaucoma [DOI]
31. 31 Comparing the Full-Threshold and Swedish Interactive Thresholding Algorithms for Short-Wavelength Automated Perimetry [DOI]
32. 32 Short-Wavelength Automated Perimetry in Low-, Medium-, and High-Risk Ocular Hypertensive Eyes [DOI]
33. 33 Statistical aspects of the normal visual field in short-wavelength automated perimetry.
34. 34 Test-retest variability of blue-on-yellow perimetry is greater than white-on-white perimetry in normal subjects [DOI]
35. 35 Frequency Doubling Perimetry in Glaucoma [DOI]
36. 36 Long-term fluctuation in short-wavelength automated perimetry in glaucoma suspects and glaucoma patients.
37. 37 Frequency doubling perimetry and the detection of eye disease in the community.
38. 38 Detecting Glaucoma with Frequency-Doubling Technology Perimetry [DOI]
39. 39 Glaucoma Detection With Frequency Doubling Perimetry and Short-wavelength Perimetry [DOI]
40. 40 Interpretation of the Humphrey Matrix 24-2 test in the diagnosis of preperimetric glaucoma [DOI]
41. 41 Frequency doubling perimetry in glaucoma early diagnosis [DOI]
42. 42 Learning effects among perimetric novices in frequency doubling technology perimetry [DOI]
43. 43 Short-Wavelength Automated Perimetry and Retinal Nerve Fiber Layer Evaluation in Suspected Cases of Glaucoma [DOI]
44. 44 Frequency Doubling Perimetry and Short-Wavelength Automated Perimetry to Detect Early Glaucoma [DOI]
45. 45 Effect of Cataract on Frequency Doubling Perimetry in the Screening Mode [DOI]
46. 46 Mild Learning Effect of Short-wavelength Automated Perimetry Using SITA Program [DOI]
47. 47 Comparison of Matrix Perimetry With Octopus Perimetry for Assessing Glaucomatous Visual Field Defects [DOI]
48. 48 The role of frequency doubling technology (FDT) in glaucoma screening [DOI]
49. 49 The Prevalence of Glaucomatous Defects With Short-Wavelength Automated Perimetry in Patients With Elevated Intraocular Pressures [DOI]
50. 50 Short-wavelength automated perimetry: Abnormality criteria [DOI]
51. 51 Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease [DOI]
52. 52 Blue-on-Yellow Perimetry Can Predict the Development of Glaucomatous Visual Field Loss [DOI]
53. 53 Screening for glaucomatous visual field loss with frequency-doubling perimetry
54. 54 Identification of glaucoma-related visual field abnormality with the screening protocol of frequency doubling technology [DOI]
55. 55 Frequency doubling technology perimetry for detection of glaucomatous visual field loss [DOI]
56. 56 Performance of nonlinear visual units in ocular hypertension and glaucoma
57. 57 Short wavelength automated perimetry, frequency doubling technology perimetry, and pattern electroretinography for prediction of progressive glaucomatous standard visual field defects [DOI]
58. 58 Lifetime Visual Disability in Open-angle Glaucoma and Ocular Hypertension [DOI]
59. 59 The Economic Implications of Glaucoma [DOI]
60. 60 Comparison of Standard Automated Perimetry, Frequency-Doubling Technology Perimetry, and Short-Wavelength Automated Perimetry for Detection of Glaucoma [DOI]
61. 61 Comparison of frequency doubling perimetry with Humphrey visual field analysis in a glaucoma practice [DOI]
62. 62 Corneal thickness measurements and frequency doubling technology perimetry abnormalities in ocular hypertensive eyes [DOI]
63. 63 Diagnostic capabilities of frequency-doubling technology, scanning laser polarimetry, and nerve fiber layer photographs to distinguish glaucomatous damage [DOI]
64. 64 Standard achromatic perimetry, short wavelength automated perimetry, and frequency doubling technology for detection of glaucoma damage [DOI]
65. 65 Performance of Frequency-Doubling Technology Perimetry in a Population-Based Prevalence Survey of Glaucoma [DOI]
66. 66 A New Rapid Threshold Algorithm for Short-Wavelength Automated Perimetry [DOI]
67. 67 Lifetime visual prognosis for patients with primary open-angle glaucoma [DOI]
68. 68 Magnocellular and parvocellular visual pathways have different blood oxygen level-dependent signal time courses in human primary visual cortex.
69. 69 Predictive value of short-wavelength automated perimetry [DOI]
70. 70 Visual Function-Specific Perimetry to Identify Glaucomatous Visual Loss Using Three Different Definitions of Visual Field Abnormality [DOI]
71. 71 Classifying Patterns of Localized Glaucomatous Visual Field Defects on Automated Perimetry [DOI]
72. 72 Learning Effect of Short-wavelength Automated Perimetry in Patients With Ocular Hypertension [DOI]
73. 73 Optimum Parameters for Short-Wavelength Automated Perimetry [DOI]
74. 74 Frequency doubling technique in patients with ocular hypertension and glaucoma [DOI]
75. 75 Short wavelength automated perimetry [DOI]
76. 76 Recent developments in automated perimetry in glaucoma diagnosis and management [DOI]
77. 77 A comparison of short wavelength automated perimetry with frequency doubling perimetry for the early detection of visual field loss in ocular hypertension [DOI]
78. 78 Evidence for a Learning Effect in Short-Wavelength Automated Perimetry [DOI]
79. 79 Utility of predictive equations for estimating the prevalence and incidence of primary open angle glaucoma in the UK [DOI]
80. 80 New developments in supra‐threshold perimetry [DOI]
81. 81 The Loss of Visual Function in Glaucoma [DOI]
82. 82 Parallel Visual Pathways [DOI]

Cited by 2

Related research

• Anxiety and Visual Field Assessment Reliability in Glaucoma Patients — shares topic coverage
• Evaluation of Antioxidants, and Haematological Indices in Glaucoma Patients: A Case Study of Bayelsa State, Nigeria — shares topic coverage
• Aniseikonia- Easy to Understand — shares topic coverage
• Health Workers Awareness and Knowledge of Glaucoma in Tertiary Hospital in Birnin Kebbi, Nigeria — shares topic coverage
• Family History of Glaucoma: A Predictive Factor? — shares topic coverage